About Male Infertility
Male infertility is a widespread disorder, which refers to a male's inability to impregnate his fertile female partner. It occurs due to deficiencies in semen, poor sperm quality, lower hormonal support, and abnormal ejaculation.
Technavio’s analysts forecast the global male infertility market to grow at a CAGR of 5.68% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global male infertility market for 2017-2021. To calculate the market size, the report considers the male infertility treatment, which includes products (drugs) and services.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Male Infertility Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• ASKA Pharmaceutical
• Halotech DNA
• Merck Serono
• Zydus Cadila Healthcare
Other prominent vendors
• AbbVie
• Apricus Biosciences
• Aytu BioScience
• Bristol-Myers Squibb
• CooperSurgical
• Medical Electronic Systems
• OvaScience
• MedITEX
• Xytex Cryo International
Market driver
• Higher occurrence of diabetes among men
• For a full, detailed list, view our report
Market challenge
• High cost associated with treatment of male infertility
• For a full, detailed list, view our report
Market trend
• Monetary growth among consumers
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by under-lying cause
PART 07: Market segmentation by technique
PART 08: Market segmentation by end-user
• Market overview
• Fertility clinics
• Hospitals and research institutes
PART 09: Geographical segmentation
• Market overview
• Male infertility market in Americas
• Male infertility market in EMEA
• Male infertility market in APAC
PART 10: Decision framework
PART 11: Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments
PART 12: Market trends
PART 13: Vendor landscape
• Competitive scenario
PART 14: Key Vendor Analysis
• ASKA Pharmaceutical
• Halotech DNA
• Merck Serono
• Zydus Cadila Healthcare
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Causes of male infertility
Exhibit 02: Snapshot: Global male infertility market 2016-2021
Exhibit 03: Stages of infertility treatment
Exhibit 04: Impact of various factors on male infertility market
Exhibit 05: Types of sperm classification
Exhibit 06: Global male infertility market 2016-2021 ($ millions)
Exhibit 07: Key parameters for vendors entering the market
Exhibit 08: Five forces analysis
Exhibit 09: Stages of diagnosis of male infertility
Exhibit 10: Facts related to oxidative stress
Exhibit 11: Global male infertility market by end-users (2016)
Exhibit 12: Risk factors in male infertility
Exhibit 13: Opportunity analysis of global male infertility market
Exhibit 14: Global male infertility market by geography 2016-2021
Exhibit 15: Snapshot: Global male infertility market by geography 2016-2021
Exhibit 16: Male infertility market in Americas 2016-2021 ($ millions)
Exhibit 17: Male infertility market in EMEA 2016-2021 ($ millions)
Exhibit 18: Male infertility market in APAC 2016-2021 ($ millions)
Exhibit 19: Estimated number of individuals with diabetes worldwide in 2015 and 2040 (millions)
Exhibit 20: Estimated cancer cases and deaths in US 2016 (in thousands)
Exhibit 21: Obesity prevalence in US 2015
Exhibit 22: Impact of drivers
Exhibit 23: Impact of challenges
Exhibit 24: Change in world’s population by age 2010-2050
Exhibit 25: Key success strategies for vendors
Exhibit 26: ASKA Pharmaceutical profile
Exhibit 27: ASKA Pharmaceutical: Strength analysis
Exhibit 28: ASKA Pharmaceutical: Strategy assessment
Exhibit 29: ASKA Pharmaceutical: Opportunity assessment
Exhibit 30: Halotech DNA: Profile
Exhibit 31: Halotech DNA: Strength analysis
Exhibit 32: Halotech DNA: Strategy assessment
Exhibit 33: Halotech DNA: Opportunity assessment
Exhibit 34: Merck Serono: Profile
Exhibit 35: Merck Serono: Strength analysis
Exhibit 36: Merck Serono: Strategy assessment
Exhibit 37: Merck Serono: Opportunity assessment
Exhibit 38: Zydus Cadila Healthcare profile
Exhibit 39: ZydusCadila Healthcare: Strength analysis
Exhibit 40: Zydus Cadila Healthcare: Strategy assessment
Exhibit 41: ZydusCadila Healthcare: Opportunity assessment
